Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity
Experimental Dermatology · 2025
DOI: 10.1111/exd.70067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Yutong Ran und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Cell Adhesion Molecules. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Basic Research Fund Project of Xi'an Jiaotong University, Medical Research Foundation of Xi'an City, Natural Science Foundation of Shaan Xi Province.
Abstract (Originalsprache)
Elevated periostin levels are commonly observed in conditions characterised by increased IgE and eosinophilia, such as bullous pemphigoid (BP), which typically presents with eosinophil infiltration and elevated IgE levels. To explore the link between periostin levels and key clinical parameters in BP, serum periostin levels were assessed in 55 classic BP patients and 55 healthy controls using ELISA. Upon admission, the BP Disease Area Index (BPDAI) score, autoantibody levels, and peripheral blood immune cells of BP patients were evaluated. The investigation also employed the Olink proteomic platform to analyse circulating proinflammatory biomarkers. The results indicated significantly higher periostin levels in BP patients, showing a strong positive correlation with BPDAI scores, which was more pronounced compared to the correlation between BPDAI scores and BP 180 IgG or eosinophil counts. Correlation analysis revealed positive links between periostin levels in serum and attributes such as urticaria/erythema lesions, total IgE levels, serum BP180 IgG, BP180 IgE, BP230 IgE, and blood eosinophil counts. The findings from the Olink proteomic analysis provided additional evidence of the connection between periostin and type II inflammation in BP, which was further validated by the observed positive correlation between periostin and IL‐13 using ELISA. Furthermore, it was observed that serum periostin levels decreased post‐effective treatment. Overall, this study underscores a compelling association between periostin expression and the activity and severity of BP, as well as its reflection of type II inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
- Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Förderung
- Basic Research Fund Project of Xi'an Jiaotong University
- Medical Research Foundation of Xi'an City
- Natural Science Foundation of Shaan Xi Province
- National Natural Science Foundation of China
Zitieren
APA
Ran, Y., Peng, X., Xia, Y., Liu, H., & Liu, Y. (2025). Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity. Experimental Dermatology. https://doi.org/10.1111/exd.70067
Vancouver
Ran Y, Peng X, Xia Y, Liu H, Liu Y. Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity. Experimental Dermatology. 2025. doi:10.1111/exd.70067
BibTeX
@article{Ran2025,
author = {Ran, Yutong and Peng, Xueting and Xia, Yumin and Liu, Hong and Liu, Yale},
title = {Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70067}
}
EUVIMED